Literature DB >> 31795745

Using Traditional Chinese Medicine to Relieve Asthma Symptoms: A Systematic Review and Meta-Analysis.

Mei-Hua Wang1, Chiehfeng Chen2,3,4,5, Mei-Ling Yeh1, Jaung-Geng Lin6.   

Abstract

Studies have demonstrated the effect of acupoint-based interventions in relieving the clinical symptoms of asthma. However, the effect of meridian-based interventions in asthma symptom relief is unknown. This systematic review and meta-analysis determined the effect of multiplex meridian interventions in asthma symptom relief. Eight electronic databases were searched for relevant randomized controlled trials (RCTs) that involved patients with asthma, were published before March 2018, used acupoint stimulation interventions targeting acupoints that correspond to meridians, and considered asthma symptom relief as an outcome. In 204 RCTs that were identified and used in a meta-synthesis, meridians were used 521 times, with the bladder meridian being the most frequently used. Furthermore, 23 RCTs were included in the meta-analysis. Egger's and inconsistency tests revealed no significant differences among the studies (P>0.05). However, the interventions differed significantly in terms of asthma symptom relief effect, as demonstrated by pairwise (odds ratio [OR]=0.28, 95% confidence interval=0.21-0.37) and network (OR=0.18, 95% credibility interval=0.08-0.41) meta-analyses. Surface under the cumulative ranking (SUCRA) revealed that the bladder-conception vessel-governor vessel-stomach multiplex meridian intervention was more effective than non-meridian interventions in relieving asthma symptoms. Additionally, either bladder-conception vessel-stomach or bladder-conception vessel-governor vessel-kidney multiplex meridians may be selected in interventions. This study suggests that practitioners target multiplex meridians, especially the meridians of the bladder and conception vessel, to effectively relieve asthma symptoms.

Entities:  

Keywords:  Acupoint; Asthma; Meta-Analysis; Multiplex Meridian; Randomized Controlled Trial; Review

Mesh:

Year:  2019        PMID: 31795745     DOI: 10.1142/S0192415X1950085X

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  Schisandrin B Attenuates Airway Inflammation and Airway Remodeling in Asthma by Inhibiting NLRP3 Inflammasome Activation and Reducing Pyroptosis.

Authors:  Xiufeng Chen; Zhen Xiao; Zhiyan Jiang; Yonghong Jiang; Wen Li; Mingjing Wang
Journal:  Inflammation       Date:  2021-06-18       Impact factor: 4.092

2.  Investigation of the Mechanisms of Chuankezhi Injection in the Treatment of Asthma Based on the Network Pharmacology Approach.

Authors:  Hao Zhu; Yuhuan Shi; Shanshan Jiang; Xiuxiu Jiao; Hui Zhu; Rong Wang; Yongfang Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.